Explain this page
Arphra AIPlain-English read on Masco Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +34.19% | +31.26% | +35.21% | +36.25% | +35.53% | +36.50% | +34.92% | +36.60% | +36.31% |
| Operating margin | +17.31% | +15.24% | +16.77% | +17.53% | +16.82% | +16.94% | +17.01% | +16.53% | +17.22% |
| EBITDA margin | +11.36% | +16.66% | +18.74% | +18.01% | +18.30% | +17.90% | +18.66% | +17.85% | +18.09% |
| EBIT margin | +9.55% | +14.99% | +16.87% | +16.10% | +16.34% | +16.58% | +16.75% | +16.70% | +16.36% |
| Pre-tax margin | +8.21% | +13.74% | +15.54% | +14.83% | +15.01% | +15.57% | +15.00% | +15.09% | +15.17% |
| Net margin | +4.85% | +9.70% | +11.40% | +10.50% | +10.71% | +10.90% | +10.58% | +11.14% | +10.86% |
| Cost structure | |||||||||
| Cost of revenue / sales | +65.81% | +68.74% | +64.79% | +63.75% | +64.47% | +64.07% | +66.03% | +64.52% | +63.92% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +16.87% | +16.01% | +18.44% | +18.73% | +18.71% | +18.35% | +18.17% | +18.49% | +19.08% |
| Effective tax rate | +30.52% | +24.14% | +22.46% | +24.72% | +24.41% | +22.93% | +23.86% | +24.27% | +23.77% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +520.51% | -347.93% | +782.76% | -1550.94% | +1080.00% | +1930.95% | +1823.21% | +1921.14% | +1944.03% |
| Return on assets (ROA) | +7.28% | +16.23% | +16.93% | +16.39% | +15.57% | +16.78% | +15.40% | +17.17% | +16.53% |
| Return on capital (ROC) | +44.66% | +41.31% | +39.68% | +43.40% | +36.23% | +40.48% | +38.41% | +37.99% | +39.87% |
| Return on invested capital (ROIC) | +12.50% | +26.29% | +26.97% | +26.00% | +23.07% | +26.03% | +23.90% | +25.60% | +25.14% |
| Asset turnover | +150.22% | +167.34% | +148.55% | +156.06% | +145.40% | +154.01% | +145.55% | +154.14% | +152.22% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +4.85% | +9.70% | +11.40% | +10.50% | +10.71% | +10.90% | +10.58% | +11.14% | +10.86% |
| Asset turnover (× revenue / assets) | +150.22% | +167.34% | +148.55% | +156.06% | +145.40% | +154.01% | +145.55% | +154.14% | +152.22% |
| Equity multiplier (× assets / equity) | +7147.44% | -2143.39% | +4623.28% | -9464.15% | +6934.67% | +11505.49% | +11837.65% | +11189.18% | +11757.98% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 1.50 | 1.67 | 1.49 | 1.56 | 1.45 | 1.54 | 1.46 | 1.54 | 1.52 |
| Fixed-asset turnover | 7.73 | 6.99 | 5.73 | 5.81 | 5.30 | — | — | — | — |
| Inventory turnover | 4.53 | 4.83 | 5.05 | 5.32 | 4.66 | — | — | — | — |
| Receivables turnover | 7.15 | 7.55 | 7.31 | 7.56 | 7.36 | — | — | — | — |
| Payables turnover | 5.27 | 6.80 | 6.15 | 6.32 | 6.02 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 51.03 | 48.32 | 49.94 | 48.26 | 49.62 | — | — | — | — |
| Days inventory outstanding (DIO) | 80.52 | 75.61 | 72.26 | 68.61 | 78.32 | — | — | — | — |
| Days payables outstanding (DPO) | 69.20 | 53.65 | 59.40 | 57.71 | 60.65 | — | — | — | — |
| Cash conversion cycle | 62.36 | 70.28 | 62.81 | 59.16 | 67.29 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 2.29 | 1.00 | 1.56 | 1.31 | 1.26 | 1.39 | 1.44 | 1.33 | 1.40 |
| FCF / Net income | 1.98 | 0.73 | 1.29 | 1.10 | 1.07 | 1.14 | 1.16 | 1.16 | 1.15 |
| FCF margin | +9.58% | +7.10% | +14.69% | +11.59% | +11.45% | +12.39% | +12.28% | +12.95% | +12.54% |
| OCF margin | +11.10% | +9.68% | +17.74% | +13.73% | +13.51% | +15.09% | +15.22% | +14.78% | +15.23% |
| CapEx / Revenue | +1.53% | +2.58% | +3.05% | +2.15% | +2.06% | +2.46% | +2.35% | +2.49% | +2.39% |
| CapEx / D&A | 0.85 | 1.54 | 1.63 | 1.12 | 1.05 | — | — | — | — |
| Stock-based comp / Revenue | +0.73% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 1.62 | 3.63 | 4.02 | 3.76 | 3.86 | 4.27 | 4.70 | 5.21 | 5.47 |
| EPS · basic | 1.63 | 3.65 | 4.04 | 3.77 | 3.88 | 4.33 | 4.79 | 5.30 | 5.49 |
| Book value / share | 0.31 | -1.04 | 0.51 | -0.24 | 0.36 | 0.21 | 0.22 | 0.23 | 0.22 |
| Tangible BV / share | -3.50 | -4.87 | -3.82 | -3.97 | -3.59 | 0.21 | 0.22 | 0.23 | 0.22 |
| Sales / share | 33.37 | 37.41 | 35.25 | 35.74 | 36.01 | 37.20 | 38.51 | 39.48 | 40.21 |
| Operating CF / share | 3.71 | 3.62 | 6.25 | 4.91 | 4.87 | 5.62 | 5.86 | 5.83 | 6.13 |
| Free cash flow / share | 3.20 | 2.66 | 5.18 | 4.14 | 4.12 | 4.61 | 4.73 | 5.11 | 5.04 |
| Dividends / share | 0.84 | 1.11 | 1.14 | 1.16 | 1.24 | 1.20 | 1.31 | 1.34 | 1.36 |
| Payout ratio | +51.97% | +30.64% | +28.30% | +30.90% | +32.22% | +29.61% | +32.08% | +30.53% | +31.13% |
| Retention ratio | +48.03% | +69.36% | +71.70% | +69.10% | +67.78% | +70.39% | +67.92% | +69.47% | +68.87% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +3.64% | -8.21% | -1.74% | -3.40% | +2.70% | +3.24% | +3.57% | +0.98% | +0.02% |
| Gross profit · YoY | — | -5.24% | +3.39% | +1.18% | -5.32% | +5.50% | -1.23% | +8.55% | +0.19% | +0.77% |
| Profit | ||||||||||
| Operating income · YoY | — | -8.76% | +0.98% | +2.69% | -7.29% | +3.46% | +3.62% | +0.67% | +5.21% | -0.05% |
| EBITDA · YoY | — | +52.05% | +3.25% | -5.56% | -1.84% | +0.46% | +7.61% | -0.93% | +2.36% | +6.01% |
| Net income · YoY | — | +107.39% | +7.84% | -9.47% | -1.46% | +4.49% | +0.25% | +9.03% | -1.54% | +10.63% |
| Operating | ||||||||||
| EBIT · YoY | — | +62.63% | +3.31% | -6.25% | -1.90% | +4.16% | +4.33% | +3.26% | -1.06% | +6.98% |
| R&D · YoY | — | — | — | — | — | — | — | — | — | — |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +124.07% | +10.74% | -6.47% | +2.66% | +10.74% | +9.90% | +10.90% | +4.99% | +16.43% |
| EPS · basic · YoY | — | +123.93% | +10.68% | -6.68% | +2.92% | +11.54% | +10.59% | +10.63% | +3.69% | +16.39% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $3.17B | $3.45B | $3.25B | $3.21B | $3.44B | $3.21B | $3.5B | $3.57B | $3.58B |
| Net debt | $2.24B | $2.99B | $2.62B | $2.58B | $2.79B | $2.56B | $2.83B | $2.87B | $2.88B |
| Net debt / EBITDA | 2.36 | 2.07 | 1.75 | 1.83 | 2.02 | 1.84 | 1.89 | 1.94 | 1.90 |
| Debt / equity | 40.63 | -14.24 | 28.03 | -60.64 | 45.81 | 73.18 | 75.29 | 74.04 | 76.32 |
| Debt / assets | +56.84% | +66.42% | +60.62% | +64.07% | +66.06% | +63.60% | +63.60% | +66.17% | +64.91% |
| Equity / assets | +1.40% | -4.67% | +2.16% | -1.06% | +1.44% | +0.87% | +0.84% | +0.89% | +0.85% |
| Coverage | |||||||||
| EBITDA / interest expense | 3.42 | 13.39 | 14.08 | 14.24 | 13.70 | 13.79 | 14.09 | 13.35 | 13.46 |
| Operating income / interest | 5.22 | 12.25 | 12.60 | 13.86 | 12.59 | 13.05 | 12.84 | 12.36 | 12.81 |
| Interest expense | $278M | $108M | $106M | $99M | $101M | $100.83M | $106.19M | $111.02M | $112.73M |
| Liquidity | |||||||||
| Current ratio | 1.76 | 1.56 | 1.68 | 1.75 | 1.81 | — | — | — | — |
| Quick ratio | 1.08 | 0.85 | 1.02 | 1.07 | 1.06 | — | — | — | — |
| Cash ratio | 0.48 | 0.24 | 0.37 | 0.41 | 0.41 | — | — | — | — |
| Working capital | $1.48B | $1.06B | $1.16B | $1.17B | $1.27B | — | — | — | — |
| Working capital / revenue | +17.71% | +12.18% | +14.57% | +14.95% | +16.75% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).